Pharmabiz

US FDA clears Mabwell’s IND application to initiate phase IIa study of novel anti-ST2 monoclonal antibody, 9MW1911 to treat moderate-to-severe COPD

US FDA clears Mabwell’s IND application to initiate phase IIa study of novel anti-ST2 monoclonal antibody, 9MW1911 to treat moderate-to-severe COPD: Shanghai Monday, December 29 ...
Pharmabiz

Harvard Medical School brings healthcare simulation programme to Indian school students providing insights of clinical scenarios

Harvard Medical School brings healthcare simulation programme to Indian school students providing insights of clinical scenarios: Our Bureau, Bengaluru Monday, December 29, 2025, ...
Pharmabiz

Italfarmaco & JCR Pharma enter commercialisation agreement for givinostat to treat Duchenne muscular dystrophy in Japan

Italfarmaco & JCR Pharma enter commercialisation agreement for givinostat to treat Duchenne muscular dystrophy in Japan: Milan, Italy Monday, December 29, 2025, 14:00 Hrs [IST] It ...
Pharmabiz

Corona Remedies announces commencement of capacity expansion for commercial production at Bhayla facility

Corona Remedies announces commencement of capacity expansion for commercial production at Bhayla facility: Our Bureau, Mumbai Monday, December 29, 2025, 13:30 Hrs [IST] Corona Rem ...
Pharmabiz

Biohaven’s phase 2 proof-of-concept study with BHV-7000 in major depressive disorder fails to meet its primary endpoint

Biohaven’s phase 2 proof-of-concept study with BHV-7000 in major depressive disorder fails to meet its primary endpoint: New Haven, Connecticut Monday, December 29, 2025, 13:00 ...
Pharmabiz

Mumbai-based NMIMS Shobhaben Pratapbhai Patel School of Pharmacy gets 3 awards at 74th IPC

Mumbai-based NMIMS Shobhaben Pratapbhai Patel School of Pharmacy gets 3 awards at 74th IPC: Our Bureau, Chennai Monday, December 29, 2025, 12:40 Hrs [IST] At the recent 74th India ...
Pharmabiz

Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy

Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy: Seattle Monday, December 29, 2025, 12:00 Hrs [IST] Omer ...
Pharmabiz

Caliway Biopharmaceuticals completes submission of IND application to US FDA for phase 2 study of CBL-514 for weight management

Caliway Biopharmaceuticals completes submission of IND application to US FDA for phase 2 study of CBL-514 for weight management: New Taipei City Monday, December 29, 2025, 11:00 H ...
Pharmabiz

Australian health advisory on counterfeit Abhayrab is "over-cautionary" and "misplaced", says IIL

Australian health advisory on counterfeit Abhayrab is "over-cautionary" and "misplaced", says IIL: Our Bureau, New Delhi Monday, December 29, 2025, 10:00 Hrs [IST] Hyderabad-based ...
Pharmabiz

IPC to host 36th Skill Development Programme on Pharmacovigilance from 9 to 13 March 2026

IPC to host 36th Skill Development Programme on Pharmacovigilance from 9 to 13 March 2026: Shardul Nautiyal, Mumbai Monday, December 29, 2025, 09:00 Hrs [IST] The Indian Pharmacop ...
Pharmabiz

VBSA Bill 2025 proposes formal repeal of AICTE Act to end decades of dual-regulatory hurdles for pharmacy education

Peethaambaran Kunnathoor, Chennai Monday, December 29, 2025, 08:00 Hrs [IST] ...
Pharmabiz

Panel asks Ministry of Ayush to improve support related to cultivation of medicinal plants

Panel asks Ministry of Ayush to improve support related to cultivation of medicinal plants: Gireesh Babu, New Delhi Monday, December 29, 2025, 08:00 Hrs [IST] The Parliamentary Pa ...